Legacies of eugenics: confronting the past, forging a future
By Marius Turda,
Ethnic and Racial Studies
| 07. 20. 2022
After 1900, eugenics became an influential scientific theory used by physicians, health experts, religious leaders and politicians across the political spectrum to express their understanding of human and social evolution and formulate their duties and responsibilities towards the nation, the race, and future generations. Physical and intellectual achievements, it was assumed, were determined by heredity. To control heredity, eugenicists claimed, was to ensure the betterment of future generations and the survival of the species. Another popular claim put forward during the first half of the twentieth century was that modern society was under constant threat from those with physical and mental disabilities (Stern 2016; Herzog 2018). Eugenicists wanted to prevent these people from having children. Protecting the so-called “feebleminded”, the constitutionally weak and the socially “unfit” was deemed detrimental to the future of the race. Finally, eugenics promised a solution to social problems as varied as crime, alcoholism, and poverty. None of these claims were substantiated by credible scientific evidence, but this did not prevent the application of eugenics on social, economic, and racial grounds. Throughout the twentieth...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...